MEDIFAST Total Revenue vs Other Operating Expenses Analysis

MED Stock

USD 18.30 0.14 0.77%

MEDIFAST INC financial indicator trend analysis is infinitely more than just investigating MEDIFAST INC recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether MEDIFAST INC is a good investment. Please check the relationship between MEDIFAST INC Total Revenue and its Other Operating Expenses accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in MEDIFAST INC. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income.

For information on how to trade MEDIFAST Stock refer to our How to Trade MEDIFAST Stock guide.

Total Revenue vs Other Operating Expenses

Total Revenue vs Other Operating Expenses Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of MEDIFAST INC Total Revenue account and Other Operating Expenses. At this time, the significance of the direction appears to have totally related.

The correlation between MEDIFAST INC's Total Revenue and Other Operating Expenses is 1.0. Overlapping area represents the amount of variation of Total Revenue that can explain the historical movement of Other Operating Expenses in the same time period over historical financial statements of MEDIFAST INC, assuming nothing else is changed. The correlation between historical values of MEDIFAST INC's Total Revenue and Other Operating Expenses is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Total Revenue of MEDIFAST INC are associated (or correlated) with its Other Operating Expenses. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Other Operating Expenses has no effect on the direction of Total Revenue i.e., MEDIFAST INC's Total Revenue and Other Operating Expenses go up and down completely randomly.

Correlation Coefficient

1.0

Relationship Direction	Positive
Relationship Strength	Very Strong

View All Relationships

Total Revenue

Total revenue comprises all receipts MEDIFAST INC generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.

Other Operating Expenses

Other Operating Expenses is the expense which generally does not depend on sales or production quantities of MEDIFAST INC. It is also known as MEDIFAST INC overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.

Most indicators from MEDIFAST INC's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into MEDIFAST INC current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in MEDIFAST INC. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income.

For information on how to trade MEDIFAST Stock refer to our How to Trade MEDIFAST Stock guide.At present, MEDIFAST INC's Discontinued Operations is projected to increase significantly based on the last few years of reporting. The current year's Enterprise Value Over EBITDA is expected to grow to 6.96, whereas Tax Provision is forecasted to decline to about 26.5 M.

	2021	2022	2023	2024 (projected)
Gross Profit	1.1B	1.1B	775.9M	814.6M
Total Revenue	1.5B	1.6B	1.1B	1.1B

Gross Profit Total Revenue

MEDIFAST INC fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Common Stock Total Equity	Common Stock Shares Outstanding	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Short Term Debt	Common Stock	Accounts Payable	Other Assets
Total Assets		0.9	0.91	0.95	0.96	0.89	-0.63	0.91	0.81	0.9	0.25	0.79	0.31	0.19	0.2	0.81	0.8	0.89	0.13	0.96	0.88	0.99	0.8	0.19	0.71	0.85
Short Long Term Debt Total	0.9		0.93	0.91	0.82	0.79	-0.46	0.78	0.66	0.82	0.4	0.61	0.25	0.0	-0.03	0.76	0.82	0.78	0.03	0.91	0.83	0.89	0.73	0.0	0.74	0.79
Other Current Liab	0.91	0.93		0.97	0.79	0.75	-0.62	0.83	0.78	0.77	0.37	0.67	0.1	0.04	0.03	0.75	0.85	0.77	-0.12	0.96	0.74	0.92	0.7	0.04	0.74	0.76
Total Current Liabilities	0.95	0.91	0.97		0.84	0.82	-0.63	0.84	0.79	0.82	0.28	0.68	0.08	0.04	0.06	0.79	0.9	0.79	-0.01	1.0	0.79	0.96	0.7	0.04	0.76	0.77
Total Stockholder Equity	0.96	0.82	0.79	0.84		0.85	-0.65	0.92	0.8	0.87	0.22	0.87	0.49	0.3	0.3	0.71	0.63	0.89	0.22	0.84	0.86	0.95	0.81	0.3	0.62	0.86
Property Plant And Equipment Net	0.89	0.79	0.75	0.82	0.85		-0.27	0.74	0.49	0.99	0.09	0.53	0.37	0.33	0.3	0.96	0.74	0.9	0.26	0.86	0.97	0.81	0.74	0.32	0.53	0.77
Net Debt	-0.63	-0.46	-0.62	-0.63	-0.65	-0.27		-0.72	-0.96	-0.28	-0.3	-0.89	-0.03	-0.14	-0.19	-0.12	-0.36	-0.41	0.12	-0.57	-0.25	-0.73	-0.45	-0.14	-0.54	-0.53
Retained Earnings	0.91	0.78	0.83	0.84	0.92	0.74	-0.72		0.84	0.74	0.22	0.87	0.34	0.29	0.33	0.61	0.63	0.8	-0.13	0.83	0.72	0.93	0.69	0.29	0.63	0.71
Cash	0.81	0.66	0.78	0.79	0.8	0.49	-0.96	0.84		0.51	0.35	0.93	0.15	0.12	0.15	0.36	0.53	0.61	-0.06	0.75	0.48	0.87	0.64	0.12	0.61	0.7
Non Current Assets Total	0.9	0.82	0.77	0.82	0.87	0.99	-0.28	0.74	0.51		0.14	0.56	0.45	0.26	0.21	0.93	0.71	0.91	0.29	0.86	0.99	0.82	0.8	0.25	0.52	0.84
Non Currrent Assets Other	0.25	0.4	0.37	0.28	0.22	0.09	-0.3	0.22	0.35	0.14		0.26	0.09	-0.04	-0.22	0.09	0.22	0.04	0.08	0.26	0.16	0.28	0.29	-0.04	0.25	0.29
Cash And Short Term Investments	0.79	0.61	0.67	0.68	0.87	0.53	-0.89	0.87	0.93	0.56	0.26		0.45	0.24	0.25	0.34	0.35	0.69	0.05	0.65	0.55	0.84	0.73	0.24	0.47	0.76
Net Receivables	0.31	0.25	0.1	0.08	0.49	0.37	-0.03	0.34	0.15	0.45	0.09	0.45		0.09	-0.03	0.26	-0.19	0.53	0.34	0.1	0.51	0.24	0.71	0.09	-0.2	0.59
Common Stock Total Equity	0.19	0.0	0.04	0.04	0.3	0.33	-0.14	0.29	0.12	0.26	-0.04	0.24	0.09		0.94	0.25	0.02	0.23	0.06	0.07	0.18	0.16	-0.04	1.0	0.2	0.0
Common Stock Shares Outstanding	0.2	-0.03	0.03	0.06	0.3	0.3	-0.19	0.33	0.15	0.21	-0.22	0.25	-0.03	0.94		0.19	0.03	0.21	-0.04	0.08	0.13	0.18	-0.13	0.94	0.21	-0.06
Non Current Liabilities Total	0.81	0.76	0.75	0.79	0.71	0.96	-0.12	0.61	0.36	0.93	0.09	0.34	0.26	0.25	0.19		0.79	0.83	0.21	0.84	0.91	0.72	0.66	0.25	0.49	0.66
Inventory	0.8	0.82	0.85	0.9	0.63	0.74	-0.36	0.63	0.53	0.71	0.22	0.35	-0.19	0.02	0.03	0.79		0.59	0.0	0.91	0.68	0.8	0.43	0.02	0.81	0.5
Other Current Assets	0.89	0.78	0.77	0.79	0.89	0.9	-0.41	0.8	0.61	0.91	0.04	0.69	0.53	0.23	0.21	0.83	0.59		0.19	0.82	0.91	0.84	0.86	0.23	0.44	0.86
Other Stockholder Equity	0.13	0.03	-0.12	-0.01	0.22	0.26	0.12	-0.13	-0.06	0.29	0.08	0.05	0.34	0.06	-0.04	0.21	0.0	0.19		0.02	0.34	0.06	0.26	0.06	-0.02	0.32
Total Liab	0.96	0.91	0.96	1.0	0.84	0.86	-0.57	0.83	0.75	0.86	0.26	0.65	0.1	0.07	0.08	0.84	0.91	0.82	0.02		0.83	0.95	0.71	0.07	0.74	0.77
Property Plant And Equipment Gross	0.88	0.83	0.74	0.79	0.86	0.97	-0.25	0.72	0.48	0.99	0.16	0.55	0.51	0.18	0.13	0.91	0.68	0.91	0.34	0.83		0.8	0.83	0.18	0.49	0.86
Total Current Assets	0.99	0.89	0.92	0.96	0.95	0.81	-0.73	0.93	0.87	0.82	0.28	0.84	0.24	0.16	0.18	0.72	0.8	0.84	0.06	0.95	0.8		0.76	0.16	0.74	0.81
Short Term Debt	0.8	0.73	0.7	0.7	0.81	0.74	-0.45	0.69	0.64	0.8	0.29	0.73	0.71	-0.04	-0.13	0.66	0.43	0.86	0.26	0.71	0.83	0.76		-0.04	0.24	0.94
Common Stock	0.19	0.0	0.04	0.04	0.3	0.32	-0.14	0.29	0.12	0.25	-0.04	0.24	0.09	1.0	0.94	0.25	0.02	0.23	0.06	0.07	0.18	0.16	-0.04		0.2	0.0
Accounts Payable	0.71	0.74	0.74	0.76	0.62	0.53	-0.54	0.63	0.61	0.52	0.25	0.47	-0.2	0.2	0.21	0.49	0.81	0.44	-0.02	0.74	0.49	0.74	0.24	0.2		0.44
Other Assets	0.85	0.79	0.76	0.77	0.86	0.77	-0.53	0.71	0.7	0.84	0.29	0.76	0.59	0.0	-0.06	0.66	0.5	0.86	0.32	0.77	0.86	0.81	0.94	0.0	0.44

Click cells to compare fundamentals

MEDIFAST INC Account Relationship Matchups

MEDIFAST INC fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	194.7M	276.1M	398.3M	316.2M	309.9M	325.4M
Other Current Liab	49.3M	57.3M	84.4M	69.1M	48.5M	50.9M
Total Current Liabilities	79.4M	111.4M	169.8M	140.9M	92.3M	96.9M
Total Stockholder Equity	104.8M	157.2M	202.5M	155.0M	201.5M	211.6M
Property Plant And Equipment Net	38.8M	38.1M	80.6M	75.6M	67.1M	70.5M
Net Debt	(63.4M)	(152.6M)	(71.6M)	(61.6M)	(72.4M)	(68.8M)
Retained Earnings	168.8M	154.4M	190.3M	139.9M	174.6M	183.4M
Cash	77.0M	163.7M	104.2M	87.7M	94.4M	99.2M
Non Current Assets Total	40.5M	41.8M	91.5M	93.4M	85.9M	90.2M
Non Currrent Assets Other	353K	2.9M	6.5M	12.5M	14.7M	15.4M
Cash And Short Term Investments	92.7M	174.5M	109.5M	87.7M	150.0M	157.5M
Net Receivables	1.0M	1.4M	584K	0.0	8.7M	9.2M
Common Stock Shares Outstanding	12.1M	11.9M	11.8M	11.3M	10.9M	12.2M
Liabilities And Stockholders Equity	194.7M	276.1M	398.3M	316.2M	309.9M	325.4M
Non Current Liabilities Total	10.4M	7.5M	26.0M	20.3M	16.1M	16.9M
Inventory	48.8M	53.4M	180.0M	118.9M	54.6M	27.8M
Other Current Assets	11.3M	12.3M	17.3M	16.2M	19.4M	20.4M
Other Stockholder Equity	(64.0M)	2.8M	12.0M	15.2M	26.6M	27.9M
Total Liab	89.8M	118.8M	195.9M	161.2M	108.4M	113.8M
Property Plant And Equipment Gross	38.8M	38.1M	113.3M	115.6M	114.4M	120.1M
Total Current Assets	154.2M	234.3M	306.9M	222.8M	224.0M	235.2M
Short Term Debt	3.2M	7.3M	6.5M	5.8M	11.8M	12.4M
Accounts Payable	22.6M	36.1M	70.9M	58.7M	39.2M	21.4M
Accumulated Other Comprehensive Income	25K	41K	111K	24K	248K	260.4K
Other Assets	1.7M	14.1M	10.9M	17.8M	20.5M	21.5M
Short Term Investments	15.7M	10.8M	5.4M	(23K)	55.6M	58.4M
Property Plant Equipment	26.0M	27.6M	56.1M	57.2M	65.8M	69.1M
Net Tangible Assets	104.8M	157.2M	202.5M	155.0M	178.3M	125.0M
Retained Earnings Total Equity	168.8M	154.4M	190.3M	139.9M	160.8M	126.9M
Capital Surpluse	0.0	7.8M	12.0M	21.6M	19.4M	10.8M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

RSI	Rush Street Interactive
OKTA	Okta Inc
BAC	Bank of America

When determining whether MEDIFAST INC is a strong investment it is important to analyze MEDIFAST INC's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact MEDIFAST INC's future performance. For an informed investment choice regarding MEDIFAST Stock, refer to the following important reports:

How To Invest In MEDIFAST

Details

Is MEDIFAST Stock a good investment?

Details

What is MEDIFAST INC's Net Worth?

Details

Largest Personal Care Products Companies

View

Largest Household & Personal Products Companies

View

Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in MEDIFAST INC. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income.

For information on how to trade MEDIFAST Stock refer to our How to Trade MEDIFAST Stock guide.

You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.

Is Personal Care Products space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of MEDIFAST INC. If investors know MEDIFAST will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about MEDIFAST INC listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

(0.95)

Earnings Share

0.67

Revenue Per Share

61.769

Quarterly Revenue Growth

(0.41)

Return On Assets

0.0477

The market value of MEDIFAST INC is measured differently than its book value, which is the value of MEDIFAST that is recorded on the company's balance sheet. Investors also form their own opinion of MEDIFAST INC's value that differs from its market value or its book value, called intrinsic value, which is MEDIFAST INC's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because MEDIFAST INC's market value can be influenced by many factors that don't directly affect MEDIFAST INC's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between MEDIFAST INC's value and its price as these two are different measures arrived at by different means. Investors typically determine if MEDIFAST INC is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, MEDIFAST INC's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

MEDIFAST Total Revenue vs Other Operating Expenses Analysis

Total Revenue vs Other Operating Expenses

Total Revenue vs Other Operating Expenses Correlation Analysis

Correlation Coefficient

Total Revenue

Other Operating Expenses

MEDIFAST INC fundamental ratios Correlations

MEDIFAST INC Account Relationship Matchups

High Positive Relationship

High Negative Relationship

MEDIFAST INC fundamental ratios Accounts

Also Currently Popular

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Liab	+ 1.0	Total Current Liabilities
Common Stock	+ 1.0	Common Stock Total Equity
Total Current Assets	+ 0.99	Total Assets
Non Current Assets Total	+ 0.99	Property Plant And Equipment Net
Property Plant And Equipment Gross	+ 0.99	Non Current Assets Total
Total Current Liabilities	+ 0.97	Other Current Liab

Cash	- 0.96	Net Debt
Cash And Short Term Investments	- 0.89	Net Debt
Total Current Assets	- 0.73	Net Debt
Retained Earnings	- 0.72	Net Debt
Net Debt	- 0.65	Total Stockholder Equity
Net Debt	- 0.63	Total Current Liabilities